Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study

BMC Public Health

Dianne O’Connell¹  Freddy Sitas³  Glenn Salkeld²  David P Smith³  Michelle Cunich²  Marianne F Weber³ 

[1]School of Public Health and Community Medicine, The University of New South Wales, Kensington, NSW 2052, Australia

[2]School of Public Health, The University of Sydney, Sydney, NSW 2006, Australia

[3]Cancer Research Division, Cancer Council NSW, PO Box 572, Kings Cross, Sydney, NSW 1340, Australia

关键词: Socioeconomic status;    Sociodemographic characteristics;    Prostate specific antigen test;    Faecal occult blood test;    Mammography;    Cancer screening;   

Others  :  1162252
DOI  :  10.1186/1471-2458-13-429

 received in 2012-10-31, accepted in 2013-04-19,  发布年份 2013

【 摘 要 】

Background

While several studies have examined factors that influence the use of breast screening mammography, faecal occult blood tests (FOBT) for bowel cancer screening and prostate specific antigen (PSA) tests for prostate disease in Australia, research directly comparing the use of these tests is sparse. We examined sociodemographic and health-related factors associated with the use of these tests in the previous two years either alone or in combination.

Methods

Cross-sectional analysis of self-reported questionnaire data from 96,711 women and 82,648 men aged 50 or over in The 45 and Up Study in NSW (2006–2010).

Results

5.9% of men had a FOBT alone, 44.9% had a PSA test alone, 18.7% had both tests, and 30.6% had neither test. 3.2% of women had a FOBT alone, 56.0% had a mammogram alone, 16.2% had both and 24.7% had neither test. Among men, age and socioeconomic factors were largely associated with having both FOBT and PSA tests. PSA testing alone was largely associated with age, family history of prostate cancer, health insurance status and visiting a doctor. Among women, age, use of hormone replacement therapy (HRT), health insurance status, family history of breast cancer, being retired and not having a disability were associated with both FOBT and mammograms. Mammography use alone was largely associated with age, use of HRT and family history of breast cancer. FOBT use alone among men was associated with high income, living in regional areas and being fully-retired and among women, being fully-retired or sick/disabled.

Conclusions

These results add to the literature on sociodemographic discrepancies related to cancer screening uptake and highlight the fact that many people are being screened for one cancer when they could be screened for two.

【 授权许可】

   
2013 Weber et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Australian Institute of Health and Welfare & Australasian Association of Cancer Registries 2012: Cancer in Australia: an overview, 2012. Cancer series no. 74. Cat. no. CAN 70. Canberra: AIHW; 2012.
• [2]Mandel JS, Church TR, Ederer F, Bond JH: Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999, 91:434-437.
• [3]Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG: Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993, 85:1311-1318.
• [4]Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE: Long-term effects of mammography screening: updated overview of the swedish randomised trials. Lancet 2002, 359:909-919.
• [5]Moyer VA: Screening for prostate cancer: U.S. Preventive services task force recommendation statement. Ann Intern Med 2012, 157:120-134.
• [6]Australian Health Technology Advisory Committee: Prostate cancer screening. Canberra: Commonwealth Department of Health and Family Services; 1996.
• [7]MacKenzie R, Chapman S, Holding S, McGeechan K: 'A Matter of faith, not science': analysis of media coverage of prostate cancer screening in australian news media 2003–2006. J R Soc Med 2007, 100:513-521.
• [8]Smith DP, Supramaniam R, Marshall VR, Armstrong BK: Prostate cancer and prostate-specific antigen testing in New south wales. Med J Aust 2008, 189:315-318.
• [9]Australian Institute of Health and Welfare: BreastScreen australia monitoring report 2009–2010. Cancer series no. 72. Cat. no. CAN 68. Canberra: AIHW; 2012.
• [10]Department of Health: Victorian population health survey. Melbourne, Victoria: Department of Health; 2008.
• [11]Birch S, Haas M, Savage E, Van Gool K: Targeting services to reduce social inequalities in utilisation: an analysis of breast cancer screening in New south wales. Aust New Zealand Health Policy 2007, 4:12. BioMed Central Full Text
• [12]Australian Institute of Health and Welfare: National bowel cancer screening program monitoring report: phase 2, july 2008- june 2011. Cancer series no. 65. Cat. no. CAN 61. Canberra: AIHW; 2012.
• [13]Holden CA, McLachlan RI, Pitts M, Cumming R, Wittert G, Agius PA, Handelsman DJ, de Kretser DM: Men in australia telephone survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older australian men. Lancet 2005, 366:218-224.
• [14]Baade PD, Youlden DR, Coory MD, Gardiner RA, Chambers SK: Urban–rural differences in prostate cancer outcomes in australia: what has changed? Medical Journal of Australia 2011, 194:293-296.
• [15]Ward PR, Javanparast S, Matt MA, Martini A, Tsourtos G, Cole S, Gill T, Aylward P, Baratiny G, Jiwa M: Equity of colorectal cancer screening: cross-sectional analysis of national bowel cancer screening program data for south australia. Aust N Z J Public Health 2011, 35:61-65.
• [16]Achat H, Close G, Taylor R: Who has regular mammograms? effects of knowledge, beliefs, socioeconomic status, and health-related factors. Prev Med 2005, 41:312-320.
• [17]Gregory TA, Wilson C, Duncan A, Turnbull D, Cole SR, Young G: Demographic, social cognitive and social ecological predictors of intention and participation in screening for colorectal cancer. BMC Public Health 2011, 11:38. BioMed Central Full Text
• [18]Weller D, Pinnock C, Silagy C, Hiller JE, Marshall VR: Prostate cancer testing in SA men: influence of sociodemographic factors, health beliefs and LUTS. Aust N Z J Public Health 1998, 22:400-402.
• [19]Cockburn J, Paul C, Tzelepis F, McElduff P, Byles J: Screening for bowel cancer among NSW adults with varying levels of risk: a community survey. Aust N Z J Public Health 2002, 26:236-241.
• [20]Swan J, Breen N, Graubard BI, McNeel TS, Blackman D, Tangka FK, Ballard-Barbash R: Data and trends in cancer screening in the united states: results from the 2005 national health interview survey. Cancer 2010, 116:4872-4881.
• [21]Carlos RC, Underwood W 3rd, Fendrick AM, Bernstein SJ: Behavioral associations between prostate and colon cancer screening. J Am Coll Surg 2005, 200:216-223.
• [22]Carlos RC, Fendrick AM, Patterson SK, Bernstein SJ: Associations in breast and colon cancer screening behavior in women. Acad Radiol 2005, 12:451-458.
• [23]Carlos RC, Fendrick AM, Ellis J, Bernstein SJ: Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening? J Am Coll Radiol 2004, 1:769-776.
• [24]Swan J, Breen N, Coates RJ, Rimer BK, Lee NC: Progress in cancer screening practices in the united states: results from the 2000 national health interview survey. Cancer 2003, 97:1528-1540.
• [25]Lemon S, Zapka J, Puleo E, Luckmann R, Chasan-Taber L: Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am J Public Health 2001, 91:1264-1272.
• [26]Carriere P, Baade P, Newman B, Aitken J, Janda M: Cancer screening in queensland men. Med J Aust 2007, 186:404-407.
• [27]Molina L, Carlos RC, Fendrick AM, Abrahamse PH, Dong Q, Bernstein SJ: Completion of colorectal cancer screening in women attending screening mammography. Acad Radiol 2004, 11:1237-1241.
• [28]Red SN, Kassan EC, Williams RM, Penek S, Lynch J, Ahaghotu C, Taylor KL: Underuse of colorectal cancer screening among men screened for prostate cancer: a teachable moment? Cancer 2010, 116:4703-4710.
• [29]Wong YN, Coups EJ: Correlates of colorectal cancer screening adherence among Men Who have been screened for prostate cancer. J Cancer Educ 2011, 26:301-307.
• [30]Weber MF, Banks E, Ward R, Sitas F: Population characteristics related to colorectal cancer testing in New south wales, australia: results from the 45 and Up study cohort. J Med Screen 2008, 15:137-142.
• [31]Banks E, Redman S, Jorm L, Armstrong B, Bauman A, Beard J, Beral V, Byles J, Corbett S, Cumming R: Cohort profile: the 45 and up study. Int J Epidemiol 2008, 37:941-947.
• [32]Mealing NM, Banks E, Jorm LR, Steel DG, Clements MS, Rogers KD: Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol 2010, 10:26. BioMed Central Full Text
• [33]The early detection of prostate cancer in general practice: supporting patient choice. http://www.usanz.org.au/uploads/29168/ufiles/6%20%20PSA%20decision%20card%20041007.pdf webcite
• [34]Medical benefits schedule statistics. http://www.medicareaustralia.gov.au/provider/medicare/mbs.jsp#N1003F webcite
• [35]Australian Bureau of Statistics: Household income and income distribution 2009–10. Cat No. 6523.0. Canberra: ABS; 2011.
• [36]Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SLT, Walters EE, Zaslavsky AM: Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 2002, 32:959-976.
• [37]Australian Bureau of Statistics: Census of population and housing. Canberra: Commonwealth of Australia; 2006.
• [38]Nickson C, Mason KE, English DR, Kavanagh AM: Mammographic screening and breast cancer mortality: a case–control study and meta-analysis. Cancer Epidemiol Biomarkers Prev 2012, 21:1479-1488.
• [39]Gattellari M, Ward JE: A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening. Patient Educ Couns 2005, 57:168-182.
• [40]Cullati S, Charvet-Berard AI, Perneger TV: Cancer screening in a middle-aged general population: factors associated with practices and attitudes. BMC Public Health 2009, 9:118. BioMed Central Full Text
• [41]Wardle J, McCaffery K, Nadel M, Atkin W: Socioeconomic differences in cancer screening participation: comparing cognitive and psychosocial explanations. Soc Sci Med 2004, 59:249-261.
• [42]Australian Institute of Health and Welfare and Australasian Association of Cancer Registries (AACR): Cancer survival in Australia 1992–1997: geographic categories and socioeconomic status. AIHW cat. no. CAN 17. Canberra: Australian Institute of Health and Welfare (Cancer Series no. 22); 2003.
• [43]Yu XQ, O'Connell DL, Gibberd RW, Smith DP, Armstrong BK: Cancer survival, incidence and mortality by area health service in NSW 1994 to 2000. Sydney: Cancer Council NSW; 2003.
• [44]O'Byrne AM, Kavanagh AM, Ugoni A, Diver F: Predictors of non-attendance for second round mammography in an australian mammographic screening programme. J Med Screen 2000, 7:190-194.
• [45]Change and adjustment in rural victoria. Presentation to the 13th ministerial rural and regional health forum, 17 august 2007. http://www.health.vic.gov.au/ruralhealth/downloads/phillips_dpi.pdf webcite
• [46]Ye J, Williams SD, Xu Z: The association between social networks and colorectal cancer screening in american males and females: data from the 2005 health information national trends survey. Cancer Causes & Control : CCC 2009, 20:1227-1233.
• [47]Forbes GM, Fritschi L, Mendelson RM, Foster NM, Edwards JT: Influences on participation in a community-based colorectal neoplasia screening program by virtual colonoscopy in australia. Aust N Z J Public Health 2004, 28:283-287.
• [48]Tong S, Hughes K, Oldenburg BB, Mar CD: Colorectal cancer screening with faecal occult blood testing: community intention, knowledge, beliefs and behaviour. Asia Pac J Public Health 2006, 18:16-23.
• [49]Ioannou GN, Chapko MK, Dominitz JA: Predictors of colorectal cancer screening participation in the united states. Am J Gastroenterol 2003, 98:2082-2091.
• [50]Ross LE, Taylor YJ, Howard DL: Trends in prostate-specific antigen test use, 2000–2005. Public Health Rep 2011, 126:228-239.
• [51]Taylor R, Ivanov O, Page A, Brotherton J, Achat H, Close G: Predictors of non-attendance from BreastScreen NSW in women who report current mammography screening. Aust N Z J Public Health 2003, 27:581-587.
• [52]Janda M, Stanton WR, Hughes K, Del Mar C, Clavarino A, Aitken JF, Tong S, Short L, Leggett B, Newman B: Knowledge, attitude and intentions related to colorectal cancer screening using faecal occult blood tests in a rural australian population. Asia Pac J Public Health 2003, 15:50-56.
• [53]Page A, Morrell S, Tewson R, Taylor R, Brassil A: Mammography screening participation: effects of a media campaign targeting italian-speaking women. Aust N Z J Public Health 2005, 29:365-371.
• [54]Slevin TJ, Donnelly N, Clarkson JP, English DR, Ward JE: Prostate cancer testing: behaviour, motivation and attitudes among western australian men. Med J Aust 1999, 171:185-188.
• [55]Cole SR, Young GP, Byrne D, Guy JR, Morcom J: Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. J Med Screen 2002, 9:147-152.
• [56]Salkeld GP, Solomon MJ, Short L, Ward J: Measuring the importance of attributes that influence consumer attitudes to colorectal cancer screening. ANZ J Surg 2003, 73:128-132.
• [57]Rauscher GH, Johnson TP, Cho YI, Walk JA: Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008, 17:748-757.
• [58]Breslow NE, Day N: Statistical methods in cancer research. Volume II- The design and analysis of cohort studies. IARC scientific publication No 82. International Agency for Research on Cancer: Lyon, France; 1987.
• [59]Willett WC, Blot WJ, Colditz GA, Folsom AR, Henderson BE, Stampfer MJ: Merging and emerging cohorts: not worth the wait. Nature 2007, 445:257-258.